'Eur heart j' presentation slideshows

Arrhythmia 341

Arrhythmia 341. Ahmad Hersi , MBBS, MSc,FRCPC Asso . Professor of Medicine& Consultant Electrophysiologist. Objectives. Identify mechanism of AF Recognize EKG of AF Discuss treatment options of AF Identify other forms of Arrhythmia.

798 views • 62 slides

Principles of anesthesia for medical students

876 views • 61 slides

Recent Developments in the World of Diabetes

July 22, 2009 . Recent Developments in the World of Diabetes. Ali A. Rizvi, MD Department of Medicine Division of Endocrinology, Diabetes, and Metabolism University of South Carolina School of Medicine.

1k views • 42 slides

Non-Coronary Intervention Circulatory Support

Non-Coronary Intervention Circulatory Support. Advanced Angioplasty 2003. Andreas Baumbach Bristol Royal Infirmary. Circulatory Support. PCI / Acute MI Cardiogenic shock. Cardiac Surgery High risk CABG Weaning Bridge to transplant Chronic Heart Failure ?. Circulatory Support.

530 views • 41 slides

761 views • 40 slides

ER Direct Case: Management of Atrial Fibrillation and Post-Treatment Bleeding in Patient with Prior TIA

ACS and Thrombosis in the Emergency Setting. ER Direct Case: Management of Atrial Fibrillation and Post-Treatment Bleeding in Patient with Prior TIA. Faculty/Presenter Disclosure. Faculty : Andre Douen, MD,PhD,FRCPC,FAHA Relationships with commercial interests:

634 views • 40 slides

Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy gbiondizoccai@gmail.com

LEFT MAIN/MULTIVESSEL DISEASE: WHEN PERCUTANEOUS CORONARY INTERVENTION, WHEN SURGERY?. Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy gbiondizoccai@gmail.com. Educational Fellowship in PCI for Young Interventionalists -

564 views • 38 slides

No conflicts of interest

The index of microvascular resistance measured acutely predicts infarct severity and left ventricular function at 3 months in patients with ST segment elevation myocardial infarction .

491 views • 33 slides

PULMONARY EMBOLI

PULMONARY EMBOLI. Kenney Weinmeister M.D. PULMONARY EMBOLI. Over 500,000 cases per year. Results in 200,000 deaths. Mortality without treatment is 30%. With therapy mortality drops to 2-8%. RISK FACTORS FOR THROMBOEMBOLIC DISEASE. Obesity has an increased risk factor of 2.9. Tobacco use:

498 views • 33 slides

Value Based Designs

Value Based Designs. Charles M. Cutler, MD, MS National Medical Director Aetna, Inc. Agenda Current state of affairs Why medication adherence matters Barriers to adherence Overcoming the barriers Next steps Questions. Medication adherence.

611 views • 29 slides

Ventricular Septal Defects

Ventricular Septal Defects. Tate Gisslen, MD Mentor: Bradley S. Marino, MD, MPP, MSCE May 6, 2011. Anatomy. 4 morphological components of septum Membranous Inlet Outlet/Infundibular Muscular/Trabecular. Anatomy. Membranous-70-80% Small Located at base, between inlet and outlet

993 views • 29 slides

482 views • 29 slides

Left Ventricular Hypertrophy

Left Ventricular Hypertrophy. Detection, significance and treatment. Pathophysiology of LVH. High BP ? ? LV wall stress Wall stress ? 1/ wall thickness LV wall thickening ? ? wall stress Myocyte hypertrophy and ? collagen matrix Mediators: Mechanical: preload & afterload

3.01k views • 27 slides

Dementia

IGHC. Dementia. Diagnostic criteria for subclinical systolic and diastolic LV function JRP A3 . Tatiana Kuznetsova , Jan A. Staessen University of Leuven, Belgium . Heart failure. Stages of heart failure.

436 views • 26 slides

Myocardial Recovery: Stem Cell Therapy - are we getting there?

Myocardial Recovery: Stem Cell Therapy - are we getting there?. Professor Anthony Mathur Queen Mary University of London Barts and the London NHS Trust. Yes. efficacy. preclinical promise?. Source and Administration in AMI Trials.

360 views • 24 slides

Chronic Coronary Artery Disease

Chronic Coronary Artery Disease. Purpose: Chronic coronary artery disease is prevalent in older adults and exists within the overall health context of the individual. Safe and effective management in this population requires consideration of risk/benefit and goals of care. Objectives:

1.01k views • 14 slides

RF Ablation of AF First Line Treatment: Pro

RF Ablation of AF First Line Treatment: Pro. Dipen Shah MD, Hopital Cantonal Universitaire de Geneve , Switzerland. Cairo Heart Rhythm 2010. Afib Ablation at the HUG: 2002-2008 487 patients. Patient characteristics. Procedural characteristics.

276 views • 11 slides

Treatment-Resistant Hypertension: Magnitude of the Problem

255 views • 6 slides

Change in thrombin generation following edoxaban 60 mg once-daily in healthy subjects

Change in thrombin generation following edoxaban 60 mg once-daily in healthy subjects. 40. 20. 0. -20. % change from baseline, thrombin peak. -40. -60. -80. -100. 36. 48. 60. 0. 12. 24. 72. Time (hours post-dose). Lip and Agnelli. Eur Heart J. 2014 .

217 views • 1 slides

HDL-c levels and non-ABCA1-specific cholesterol efflux capacity after CETP-inhibition or placebo

HDL-c levels and non-ABCA1-specific cholesterol efflux capacity after CETP-inhibition or placebo. 70. 60. placebo. 30. dalcetrapib. 50. HDL-cholesterol (mg/dL). 20. % change from baseline in non-ABCA1-specific cholesterol efflux. 40. placebo. dalcetrapib. 30. 10. 20. 0. 0. 4. 8.

139 views • 1 slides